Functional immunoassays using an in-vitro malaria liver-stage infection model: where do we go from here?
about
Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infectionMalaria vaccines: identifying Plasmodium falciparum liver-stage targetsEnhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine.Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine.Towards an optimized inhibition of liver stage development assay (ILSDA) for Plasmodium falciparum.A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.
P2860
Functional immunoassays using an in-vitro malaria liver-stage infection model: where do we go from here?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Functional immunoassays using ...... del: where do we go from here?
@en
Functional immunoassays using ...... del: where do we go from here?
@nl
type
label
Functional immunoassays using ...... del: where do we go from here?
@en
Functional immunoassays using ...... del: where do we go from here?
@nl
prefLabel
Functional immunoassays using ...... del: where do we go from here?
@en
Functional immunoassays using ...... del: where do we go from here?
@nl
P2093
P356
P1476
Functional immunoassays using ...... del: where do we go from here?
@en
P2093
Brent L House
John B Sacci
Michael R Hollingdale
P304
P356
10.1016/J.PT.2009.08.004
P577
2009-09-09T00:00:00Z